Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
FAQ
- What is ArriVent BioPharma, Inc.'s EBITDA?
- ArriVent BioPharma, Inc. (AVBP) reported EBITDA of -$46.67M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s EBITDA changed year-over-year?
- ArriVent BioPharma, Inc.'s EBITDA increased by 30.9% year-over-year, from -$67.53M to -$46.67M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about ArriVent BioPharma, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude